Drugs / Fuke Qianjin capsule
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04723069 | Sep 2021 → Mar 2022 | pelvic inflammatory disease | University of Karachi | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fuke Qianjin capsule | “Fuke Qianjin capsule is consecutively taken for 28 days.” NCT04723069 ↗ |
| Known as | FUKE | “two Fuke Qianjin (FUKE) capsules, three times a day after a meal for 28 days.” PMID 38584600 ↗ Mar 2024 |
| Route | Oral | “Fuke Qianjin Capsules and their simulants are taken as 2 capsules at a time, 3 times a day, orally after breakfast, lunch and dinner, respectively” NCT04723069 ↗ |